Intarcia Therapeutics is dedicated to redesigning the treatment of chronic disease. They are rethinking the future of medicine with people at the center of the experience.

Biotechnology

Education

Intarcia Therapeutics

Kurt Graves

Ajay Mohite

Paul Henriques

Mingfang (Ming) Chen

Tom Armstrong

Minoo Niknian, PhD

Debra Platek

Andrew Young

Thomas Alessi

Paul Feldman

Fred Fiedorek

Anthony Hurley

The leadership team at Intarcia Therapeutics has a wealth of experience in the healthcare and pharmaceutical industries. Advisors have worked with New Rhein Healthcare Investors, and the Chief Scientific Officer and co-founder have experience with Phoundry Pharmaceuticals Inc. The team is also experienced with GlaxoSmithKline, where the VP and Head Enteroendocrine Biology has worked. Lastly, the CMO has experience with Leptos Biomedical. All members of the team have received education from The University of Auckland in Physiology.

Leadership Team

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Intarcia Therapeutics

CEO and Executive Team